Pfizer Buy, Sell, Hold: 2026 Stock Outlook and Strategy
Pfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesPfizer faced a post-pandemic revenue shift, but the 2026 landscape still offers income and defensive upside. This gui...
A single data point is grabbing attention: XRP-led real-world asset tokenization is surpassing ETH and SOL inflows. W...
Claudia Sahm, a former Federal Reserve economist and creator of a recession signal, says Kevin Warsh’s policy views c...
If you want a simple path to long-term wealth, focus on sturdy businesses that are temporarily undervalued. Here are ...
BChat offers a new kind of private messaging built on a decentralized network. This article explains how it works, wh...
A doorbell moment can feel like a test of trust. When a delivery driver doesn’t match the app photo, it can raise rea...
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...
In mid-2026 markets, Dave Ramsey endorses a disciplined $5,000 index-fund starting point over chasing a single-stock ...
A major Ethereum Layer-2 network, Taiko, halted block production after an exploit. Blockaid suggests the root cause l...
As AI reshapes the job market, a leading tech founder argues Gen Z should pursue two college majors to stay competiti...
A disturbing case shows how a city inspector could steer repair funds to relatives. This article breaks down what hap...
EDX Markets secures a $76 million Series C from SBI Holdings, marking a rare instance of a single investor backing an...